Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species
about
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesCurrent ebola vaccinesA Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbolavirus vaccines for humans and apesFiloviruses: One of These Things is (not) Like the OtherEbola virus vaccines: an overview of current approachesAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccineNeglected filovirusesAd35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus speciesWhat is Ebola?Ebola and Marburg virus vaccines.Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirusExpression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Towards broad protection against Ebolaviruses.Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus.Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverageCamouflage and misdirection: the full-on assault of ebola virus diseaseHuman Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruziTackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infectionsFilovirus vaccines.Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections.Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and FilovirusesProgress in filovirus vaccine development: evaluating the potential for clinical use.Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.
P2860
Q21090120-6024E468-CDDB-43C4-9223-AD4D394C3943Q21534720-2D987978-4820-4EAD-830D-6B52B2F60C02Q24289295-BAB42057-8EF5-447A-AA33-CE54419C3101Q24597625-EFC442B5-B700-44A2-98BC-BD8E33B82F02Q24631696-B964EFA7-26CA-4A17-A1F3-9EDD98D0D2AAQ26783063-930FE065-CDF3-499C-B97A-3DA6EE8C4BAFQ26999232-18E9213B-08B9-43DD-BB8A-76799D61CEA6Q27334697-B85D8889-B874-48C1-9AE0-5DA8666CAA12Q28383265-F3A4BDED-1F0D-42FD-9C2E-596851B1127DQ28485505-189018AC-C642-4875-A9E9-0272ED52F5EEQ30205723-8A619B93-CC22-42A7-8E93-0C8BA3C9E9F7Q30234637-B4699E7D-BB78-4D06-91F2-0FAE5DDA0D32Q30724121-358F0022-7DE1-44CA-AB78-1CFD8D55EC27Q33619065-30849AAC-475D-4699-9FD9-A8B963AB0A7FQ33745567-EB1B36B8-5E6C-4218-8880-44A623DD3A5AQ33930497-CB5D2933-EB5A-49DA-A1DB-C7BEE5AB9C10Q34277020-3DDCCAB0-FBF7-4789-B18E-EE6FDE83A5EEQ34437167-B9C826C3-1F4A-432A-BA2B-3DDD643A8B91Q34440836-43DAABBC-94CD-4D8C-8213-E0723383D078Q34449079-8B3DA1FC-20BB-41B6-B7F6-742B080A1ADDQ34463780-B6ACAEAF-914E-4A3F-A780-A9CD458E1E78Q34632946-CC84C5DA-D2BF-4879-ACFC-0C7846291420Q34761889-34C00EF9-28F5-4C60-9D24-FF018D4B851FQ34931648-5A9922A9-45AB-4930-8972-D61D18022886Q34971349-8F69D7A3-F1AA-48B3-8EA1-96F8EBEF8713Q35192417-7C2C2291-2FCE-4735-8203-B2802B423784Q35202880-3FFCEF96-A586-411F-B12C-F83547D59105Q35275167-7632AAF2-A7A2-4462-858A-2903B6515319Q35300062-0151D733-DB49-46A5-BA81-69F381F81C4EQ35531542-45A44761-4EBC-4756-822A-219EC2DB8863Q35557184-90A6D51D-D73D-4718-85E2-CFF5CDBC5370Q35558539-79EFD9D8-4707-4D87-8E50-68BA943C6EA8Q35693152-B546888E-D7B8-4287-9989-CE20E742CEF8Q36043269-5473C118-D356-4ED5-8B54-47A0933D3CBEQ36100545-782C0B7A-100D-45E9-B6BF-7CBF1101082CQ36210186-16A04F74-8989-426C-B265-8DC40E068319Q36356863-D3F3740D-0C7A-44A3-82AE-91F3F47E4348Q36474557-47526667-B2ED-41F4-860B-260CD424B889Q36759944-AA6C66C5-FE3A-4225-8D0E-246258FD6052Q36995725-3FFE0ABD-0722-405B-86BA-A195915D2A43
P2860
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@ast
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@en
Demonstration of cross-protect ...... pathogenic Ebolavirus Species.
@nl
type
label
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@ast
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@en
Demonstration of cross-protect ...... pathogenic Ebolavirus Species.
@nl
prefLabel
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@ast
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@en
Demonstration of cross-protect ...... pathogenic Ebolavirus Species.
@nl
P2093
P2860
P50
P1433
P1476
Demonstration of cross-protect ...... pathogenic Ebolavirus Species
@en
P2093
Clement Asiedu
Daphne Stanley
Giulia Fabozzi
Mario Roederer
Michael Bailey
Nancy J Sullivan
Richard A Koup
Sabue Mulangu
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000904
P50
P577
2010-05-20T00:00:00Z